# Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular Activity

> **NCT07741773** · NA · NOT_YET_RECRUITING · sponsor: **Augusta University** · enrollment: 20 (estimated)

## Conditions studied

- Mild Cognitive Impairment (MCI)

## Interventions

- **DIETARY_SUPPLEMENT:** EVOO-phenolics dietary supplement
- **DIETARY_SUPPLEMENT:** Placebo

## Key facts

- **NCT ID:** NCT07741773
- **Lead sponsor:** Augusta University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-08-31
- **Final completion:** 2028-08-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07741773

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07741773, "Assessing Treatment With High-phenolic EVOO Supplements for Neurovascular Activity". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07741773. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*